SC 13G Filing

Company

Aptose Biosciences Inc.

Filed

February 27, 2006

Accession Number

0001178913-06-000362

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →